Form 4: SeaStar Medical Director Awarded 3,000 RSUs

SeaStar Medical Holding Corp. Director Jennifer A. Baird received an award of 3,000 Restricted Stock Units (RSUs) on February 6, 2026, which will vest in full on February 6, 2027.

Summary

• Jennifer A. Baird, a Director of SeaStar Medical Holding Corp. (ICU), was granted 3,000 Restricted Stock Units (RSUs).
• The transaction occurred on February 6, 2026.
• The RSUs were acquired at a price of $0 per share.
• These RSUs will vest in full on February 6, 2027.
• Following this transaction, Jennifer A. Baird directly beneficially owns 6,620 shares of Common Stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as the equity grant to a director strengthens alignment between management and shareholder interests, incentivizing long-term performance.

Positives

• The grant of 3,000 Restricted Stock Units (RSUs) to Director Jennifer A. Baird aligns her interests with those of shareholders, as the value of the award is tied to the company's stock performance.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that equity grants to directors are a standard practice across industries to incentivize long-term commitment and align leadership interests with shareholder value creation. This type of compensation is common in biotechnology and medical device companies like SeaStar Medical, where long development cycles often necessitate retention strategies for key personnel.

Comparison to Industry Standards

• The grant of 3,000 RSUs to a director is within typical ranges for non-executive director compensation in small-cap biotechnology firms, comparable to grants seen at companies such as Athersys, Inc. (ATHX) or Organogenesis Holdings Inc. (ORGO) for similar roles, which often include a mix of cash and equity to ensure alignment with company performance.

Stakeholder Impact

• Shareholders: The RSU award aligns the director's financial interests with the company's long-term performance, potentially benefiting shareholders through improved governance and strategic decisions.

Next Steps

• The 3,000 Restricted Stock Units (RSUs) are scheduled to vest in full on February 6, 2027.

Key Dates

Recommendation

This Form 4 reports a routine equity grant to a director, which is a standard compensation practice. It does not provide new information that would fundamentally alter the investment thesis for SeaStar Medical Holding Corp., thus a 'hold' recommendation is maintained.

Keywords

SeaStar Medical Holding Corp, ICU, Jennifer A. Baird, Form 4, Insider Transaction, Restricted Stock Units, RSU Award, Director Compensation, Equity Grant